Risk assessment and perspectives of local transmission of chikungunya and dengue in Italy, a European forerunner.

Publication date: Jul 07, 2025

To address the growing frequency, extension, and size of local arboviral outbreaks in Europe we retrospectively analyzed dengue and chikungunya transmission in Italy from 2006 to 2023. We applied generalized additive models to the records of travel-related cases to highlight the spatiotemporal patterns of disease importation, calculated reproduction numbers for six local outbreaks based on autochthonous case data and mapped current transmission risks by applying a computational model that integrates human density, entomological, and climate data. Outbreak locations appear driven by case importation, which is notably higher for dengue – especially from June to October – rather than local transmission risks. Although reporting delays and favorable temperatures allowed onward transmission for several generations from mid-August to mid-November, upon outbreak detection control of transmission was achieved within 15 days. In high-risk areas, significantly longer epidemic risks were found for chikungunya (over 4 months). However, considering observed importation trends, increasingly frequent local dengue outbreaks are expected. Case detection should be prioritized focusing on areas, and in times, where environmental and climate conditions are permissive, regardless of prior outbreaks.

Open Access PDF

Concepts Keywords
Dengue Aedes
Entomological Animals
Italy Chikungunya Fever
June Chikungunya virus
October Dengue
Dengue Virus
Disease Outbreaks
Humans
Italy
Mosquito Vectors
Retrospective Studies
Risk Assessment
Travel

Semantics

Type Source Name
disease MESH dengue
pathway REACTOME Reproduction
disease IDO country
disease MESH Infectious Diseases
disease IDO symptom
disease MESH infection
disease MESH COVID 19 pandemic
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH arthralgias
disease MESH meningoencephalitis
disease MESH bleeding
disease MESH petechiae
drug DRUGBANK Coenzyme M
disease MESH autochthonous transmission
disease IDO history
drug DRUGBANK Flunarizine
disease MESH imported infections
disease IDO host
drug DRUGBANK Fenamole
drug DRUGBANK N-Cyclohexyltaurine
drug DRUGBANK Water
disease MESH viral infection
disease MESH severe dengue
disease MESH emergencies
disease MESH arbovirus infection
drug DRUGBANK Cysteamine
disease IDO pathogen
disease MESH uncertainty
disease MESH secondary infections
disease IDO susceptible population
pathway REACTOME Infectious disease
disease IDO infectious disease
drug DRUGBANK L-Aspartic Acid
drug DRUGBANK Trestolone
drug DRUGBANK Serine
disease MESH Chikungunya virus infection
disease IDO blood

Original Article

(Visited 9 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *